G1 Therapeutics, Inc. Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in G1 Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in G1 Therapeutics, Inc. for January 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29 2021 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Chief Medical Offic ... | Option Exercise | M | 0.39 | 3,100 | 1,209 | 79,844 | |
| Jan 29 2021 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Chief Medical Offic ... | Buy | M | 0.39 | 3,100 | 1,209 | 43,300 | 40.2 K to 43.3 K (+7.71 %) |
| Jan 22 2021 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Chief Medical Offic ... | Option Exercise | M | 4.17 | 15,000 | 62,550 | 41,519 | |
| Jan 22 2021 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Chief Medical Offic ... | Sell | S | 20.64 | 15,000 | 309,591 | 40,200 | 55.2 K to 40.2 K (-27.17 %) |
| Jan 22 2021 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Chief Medical Offic ... | Buy | M | 4.17 | 15,000 | 62,550 | 55,200 | 40.2 K to 55.2 K (+37.31 %) |
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 3.72 | 10,000 | 37,200 | 59,433 | ||
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 4,000 | 1,560 | 367,286 | ||
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 3.72 | 10,000 | 37,200 | 69,433 | ||
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 3.72 | 10,000 | 37,200 | 79,433 | ||
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.64 | 10,000 | 206,400 | 41,000 | 51 K to 41 K (-19.61 %) | |
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 3.72 | 10,000 | 37,200 | 51,000 | 41 K to 51 K (+24.39 %) | |
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 4,000 | 1,560 | 41,000 | 37 K to 41 K (+10.81 %) | |
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 21.51 | 10,000 | 215,107 | 37,000 | 47 K to 37 K (-21.28 %) | |
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 3.72 | 10,000 | 37,200 | 47,000 | 37 K to 47 K (+27.03 %) | |
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.88 | 10,000 | 208,781 | 37,000 | 47 K to 37 K (-21.28 %) | |
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 3.72 | 10,000 | 37,200 | 47,000 | 37 K to 47 K (+27.03 %) | |
| Jan 05 2021 | GTHX | G1 Therapeutics, I ... | Bailey John E. (Jack) Jr. | President and CEO | Option Exercise | A | 17.99 | 320,000 | 5,756,800 | 320,000 | |
| Jan 05 2021 | GTHX | G1 Therapeutics, I ... | Bailey John E. (Jack) Jr. | President and CEO | Grant | A | 0.00 | 213,333 | 0 | 221,333 | 8 K to 221.3 K (+2,666.66 %) |